Left-side positioning for pregnancies with fetal growth restriction
Official title: Impact of Maternal Left-Lateral Recumbent Positioning in Pregnancies With Fetal Growth Restriction
Run by University of Colorado, Denver · NCT06919692 · Data updated 2026-11-12
This trial tests whether pregnant people with fetal growth restriction who lie on their left side for several hours a day help their baby grow better and affect maternal and fetal health measures.
Quick facts
| Study type | Interventional |
|---|---|
| Ages | 18 Years to 65 Years |
| Sex | Women only |
| Enrollment | 100 (estimated) |
| Sponsor | University of Colorado, Denver Academic / other |
| Locations | 2 sites (Aurora, Colorado and 1 other locations) |
| Status | Recruiting |
| Started | July 28, 2025 |
| Main results expected | June 3, 2026 |
| Study ends | December 3, 2026 |
| Registry record updated | July 17, 2025 |
| Trial ID | NCT06919692 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Pregnant people aged 18–65 with a singleton pregnancy at 24–34 weeks, an estimated fetal weight under the 10th percentile, and fluency in English or Spanish are eligible and most likely to qualify.
✕Probably not a fit
People with severe umbilical artery Doppler abnormalities (AEDF/REDF), known hypercoagulability or prior thromboembolism, BMI > 40, those on anticoagulation, multifetal or chromosomally abnormal pregnancies, or active smokers are excluded and unlikely to benefit from this protocol.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
Participants with a singleton pregnancy between 24 and 34 weeks and an estimated fetal weight below the 10th percentile are assigned to practice left-lateral recumbent positioning for a cumulative 4 hours per day with brief stretching after each hour, or to receive standard care without scheduled left-side positioning. Researchers will compare fetal biometry over time as the primary outcome and will also measure maternal metabolomics, maternal mental health, fetal cardiac function, and delivery outcomes. The intervention is noninvasive and home-based, with regular clinic visits at the enrolling centers for measurements and monitoring. Exclusion criteria remove pregnancies with significant umbilical artery Doppler abnormalities, clotting disorders, high pre-pregnancy BMI, multifetal or chromosomal anomalies, active anticoagulation, or active smoking.
Why it matters
Potential benefit: If successful, daily left-side positioning could offer a simple, low-cost way to improve fetal growth and related birth outcomes in pregnancies affected by fetal growth restriction.
How similar studies have gone: Prior work shows maternal position can change hemodynamics, but using daily left-lateral positioning specifically to improve fetal growth in fetal growth restriction is relatively untested.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: * Pregnant persons between 18 - 65 years of age, with a diagnosis of fetal growth restriction, with an estimated fetal weight less than tenth percentile * Participants with a singleton pregnancy between 24- and 34-weeks' gestational age * Participants with fluency in English or Spanish language Exclusion Criteria: * Patients with a known history of deep vein thrombosis, pulmonary embolism, or hypercoagulability disorder * Patients with a pre-pregnancy BMI greater than 40 * Pregnancy with severe abnormality in umbilical artery Doppler flow, including absent end-diastolic flow (AEDF) and reverse end-diastolic flow (REDF) * Patients receiving anticoagulation therapy * Pregnancy with suspected chromosomal anomalies or a multifetal pregnancy * Patients with an active smoking status during pregnancy
Where it's running
-
UCHealth Prenatal Diagnosis and Genetics Clinic - Anschutz Medical Campus
Aurora, Colorado, United States Recruiting -
CU John C. Hobbins Perinatal Center
Denver, Colorado, United States Recruiting
Study contacts
- Principal investigator: Manesha Putra, MD — University of Colorado Anschutz, Department of Obstetrics and Gynecology
- Study coordinator: Hannah E Vincent, PhD
- Email: hannah.vincent@cuanschutz.edu
- Phone: 7209191019
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Fetal Heart Function in Growth-Restricted Pregnancies
This study tests whether fetal echocardiography using a modified Tei index (Mod-MPI) can reveal early heart changes in pregnancies affected by fetal growth restriction (IUGR).
-
Combined first-trimester screening for pregnancy complications
This project tests a standardized first-trimester screening to see if it can identify pregnant women at 11–13 weeks who are at higher risk for preeclampsia, fetal growth restriction, chromosomal problems, and other serious complications.
-
Examining placental blood flow using contrast ultrasound in pregnancies with growth restriction
This study is testing how well blood flows in the placenta of women having a medical termination of pregnancy, comparing those with and without fetal growth restriction to learn more about these conditions.
-
L-citrulline supplementation during pregnancy to reduce adverse birth outcomes in Kenyan women at risk of malaria.
This trial will test whether taking a twice-daily L-citrulline supplement during pregnancy helps Kenyan women at risk of malaria have healthier pregnancies and babies.
-
Comparing two methods for inducing labor in pregnancies with fetal growth restriction
This study is testing whether using a balloon to help start labor is better than using medication for women with babies that aren't growing well, to see if it leads to fewer C-sections and healthier babies.
-
Using echocardiography to diagnose fetal growth issues in twin pregnancies
This study is testing if a special heart ultrasound can help doctors spot growth problems in twins before they are born, while also looking at how air pollution might affect their health.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.